Operating Cash Flow (Statement)

€436.15M

Quarterly · Period ending: Jun 30, 2026 · EUR

Latest reported€436.15M EURperiod endingJun 30, 2026

BMXMF Quarterly Cash from Operations · EUR (€101.70M → €436.15M)

Quarterly operating cash flow (statement)

High-resolution chart · PNG

BMXMF operating cash flow (statement) history

Quarterly · EUR. Dates are reporting period ends; fiscal years can differ from calendar years.

bioMérieux S.A. Operating Cash Flow (Statement) — Quarterly (EUR)
Period ending	Operating Cash Flow (Statement) (EUR)
Jun 30, 2026	436,146,135
Dec 31, 2025	470,623,667
Jun 30, 2025	317,500,000
Dec 31, 2024	470,200,000
Jun 30, 2024	197,100,000
Dec 31, 2023	297,500,000
Jun 30, 2023	147,900,000
Dec 31, 2022	324,200,000
Jun 30, 2022	150,900,000
Dec 31, 2021	525,300,000
Jun 30, 2021	285,800,000
Dec 31, 2020	322,100,000
Jun 30, 2020	260,700,000
Dec 31, 2019	232,600,000
Jun 30, 2019	175,300,000
Dec 31, 2018	255,500,000
Jun 30, 2018	144,300,000
Dec 31, 2017	195,900,000
Jun 30, 2017	145,400,000
Dec 31, 2016	193,900,000
Jun 30, 2016	141,700,000
Dec 31, 2015	200,400,000
Jun 30, 2015	109,600,000
Dec 31, 2014	191,200,000
Jun 30, 2014	107,100,000
Dec 31, 2013	138,800,000
Jun 30, 2013	101,700,000